Aurinia Pharmaceuticals IncAurinia Pharmaceuticals IncAurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc

No trades
See on Supercharts

Price target

10.140.00 0.00%
The 7 analysts offering 1 year price forecasts for AUPH have a max estimate of — and a min estimate of —.

Analyst rating

Based on 8 analysts giving stock ratings to AUPH in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

AUPH EPS for the last quarter is −0.07 USD despite the estimation of −0.14 USD. In the next quarter EPS is expected to reach 0.01 USD. Track more of Aurinia Pharmaceuticals Inc financials and stay on top of what is up with the company.
In the next quarter Aurinia Pharmaceuticals Inc revenue is expected to reach ‪54.11 M‬ USD. Check out Aurinia Pharmaceuticals Inc revenue and earnings and make informed decisions.
According to analysts, AUPH price target is 10.14 USD with a max estimate of 15.00 USD and a min estimate of 6.00 USD. Check if this forecast comes true in a year, meanwhile watch Aurinia Pharmaceuticals Inc stock price chart and keep track of the current situation with AUPH news and stock market news.
We've gathered opinions of 8 analysts rating AUPH stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.